HIGHLIGHTS
- who: Ryan A. Bottens and Tohru Yamada from the Department of Surgery, Division of Surgical Oncology, College of Medicine, University of Illinois, Chicago, IL, USA have published the Article: Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer, in the Journal: Cancers 2022, 14, 5546. of 30/09/2022
- what: The aim of the first-in-class, first-in-human dose acceleration study was to determine the No Observed Adverse Effect Level (NOAEL) and maximum tolerated dose (MTD) of p28 in adult patients with advanced solid tumors.
- how: The results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.